
US-listed unusual-volume stocks versus 50-day averages, including POM, RBNE, CHOW, SHFS, RENT, AARD, RCT, MKDW, BRAI and XXII.
AARD is up 9.23% today. Volume is 1.40M vs a 30-day average of 1.01M (1.40x).
Aardvark Therapeutics, Inc. is scheduled to report earnings Thu, Nov 12, 2026. Analysts expect EPS of $-0.71. Stocks often move sharply on earnings day.

US-listed unusual-volume stocks versus 50-day averages, including POM, RBNE, CHOW, SHFS, RENT, AARD, RCT, MKDW, BRAI and XXII.

Unusual volume in US small-cap stocks: RBNE, SHFS, AARD, XXII and others traded well above 50-day averages, with sharp losses and double-digit gains.
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aardvark Therapeutics (NASDAQ:AARD) with a Neutral and lowers the price target from $4 to $2.

Top US market movers today: CLRO gained 76.04% among gainers, while AARD fell 61.52% among losers in the session.